Attention-Deficit Hyperactivity Disorder

The US Food and Drug Administration has approved a new nonstimulant drug for the treatment for attention-deficit/hyperactivity disorder in children.

The US Food and Drug Administration has approved the marketing of the first video game-based digital therapeutic device for the treatment of children aged 8 to 12 years with attention deficit hyperactivity...

The FDA has cleared for marketing the first medical device for the treatment of attention-deficit/hyperactivity disorder

The FDA has approved a new option for the treatment of adolescents and adults with ADHD.

The US Food and Drug Administration has approved a new generic option for the treatment of attention-deficit/hyperactivity disorder.

The US Food and Drug Administration has approved the stimulant lisdexamfetamine to treat binge-eating disorder, the first product to be approved for the condition.